CFI Integrates IGRA Testing in TB Active Case Finding
Last June 10, 2025, Culion Foundation, Inc. (CFI), in collaboration with Ritemed and the QCHD - National Tuberculosis Program, launched a new initiative to strengthen TB detection by introducing the Interferon Gamma Release Assay (IGRA) as another form of TB testing...